
AbbVie to buy Allergan for $63 billion
American biopharmaceutical company AbbVie has agreed to buy global pharmaceutical company Allergan in a $63 billion cash and stock deal.
American biopharmaceutical company AbbVie has agreed to buy global pharmaceutical company Allergan in a $63 billion cash and stock deal.